Congratulations to Apexian Pharmaceuticals, which licenses technology through the Indiana University Innovation and Commercialization Office. Mark R. Kelley, Apexian Pharmaceuticals’ chief scientific officer, is the Betty and Earl Herr Chair in Pediatric Oncology Research and a professor in the Department of Biochemistry and Molecular Biology and the Department of Pharmacology and Toxicology at the Indiana University… Read more »
Entrepreneurship
Register now for a Nov. 28 seminar for women and underrepresented minorities about federal SBIR and STTR grants
Maria Labreveux, executive director of the Kentucky Science and Engineering Foundation, is scheduled to speak Tuesday, Nov. 28, to women and underrepresented minority researchers and entrepreneurs at IUPUI and the IU School of Medicine. The topic will be federal Small Business Innovation Research and Small Business Technology Transfer grant programs. The hourlong seminar will be… Read more »
IUPUI researcher to promote high-tech device during Indianapolis forum Oct. 27
M. Terry Loghmani, associate professor of physical therapy in the Indiana University School of Health and Rehabilitation Sciences, will speak about a medical device system developed at IUPUI during an event today, Oct. 27. The Invention to Startup Forum is scheduled for 12:30-1:30 p.m. at the Indiana Center for Biomedical Innovation, 1800 N. Capitol Ave., in… Read more »
Eleven startups founded by Bloomington residents named to the B-Start program
B-Start, a pre-accelerator program for early-stage startups in Bloomington, has announced its 2017 cohort. Eleven startups were selected to participate in the 22-week program, during which they will attend workshops in lean business concepts, customer acquisition, fundraising, marketing and more. The 11 B-Start participants are: Adventure Field Guides: Marketplace of trip guides made by a… Read more »
Apexian Pharmaceuticals selected for NCI SBIR Investor Initiatives program
Congratulations to Indianapolis-based Apexian Pharmaceuticals, a clinical-stage biotech company developing novel compounds to treat cancer by leveraging intellectual property discovered at the Indiana University School of Medicine. The company has been selected to participate in the National Cancer Institute’s SBIR Investor Initiatives program. As part of the program, Dr. Richard Messmann — Apexian’s chief medical… Read more »
JagStart informational workshops for IUPUI, IUPUC students begin Oct. 31
Full- and part-time undergraduate, graduate and professional students who are currently enrolled and in good standing at IUPUI or IUPUC are invited to an hourlong workshop to learn about the JagStart pitch competition. JagStart encourages entrepreneurially oriented students to develop their ideas and present them persuasively. During the competition, which will take place in the… Read more »
Kelley School of Business’ entrepreneurship program, faculty receive international recognition
Congratulations to the Indiana University Kelley School of Business’ entrepreneurship program. U.S. News and World Report ranked it the top program among those offered by public universities, and third overall. It also has been cited in a paper in the Journal of Small Business Management as having the greatest impact on the field. Three Kelley… Read more »
Two IU-based startups named New Venture Competition finalists
Congratulations to Indiana Lysis Technologies and The Bee Corp., two of the five finalists in the sixth annual BioCrossroads New Venture Competition. Indiana Lysis Technologies was founded by Dr. Jeffrey Kline and Nathan Alves, faculty in the Indiana University School of Medicine’s Department of Emergency Medicine. Indiana Lysis Technologies is a drug-discovery company that is… Read more »
Approaching the Summit: Jennifer Finefield, IU Innovation and Commercialization Office
Jennifer Finefield, senior manager at the Indiana University Innovation and Commercialization Office, is one of the organizers of the Oct. 5 Commercialization and Entrepreneurship Summit on the IUPUI campus. The event will start at 8:30 a.m. in Hine Hall Auditorium, 875 W. North St. Finefield oversees patenting, marketing and licensing of technology emanating from the… Read more »
Approaching the Summit: Aoy Tomita-Mitchell, TAI Diagnostics and Ariosa Diagnostics
Aoy Tomita-Mitchell, co-founder of biotechnology companies TAI Diagnostics and Ariosa Diagnostics, will be a keynote speaker at the Oct. 5 Commercialization and Entrepreneurship Summit on the IUPUI campus. The event will start 8:30 a.m. at Hine Hall Auditorium, 875 W. North St. Tomita-Mitchell is a professor in the Department of Surgery, Division of Pediatric Cardiothoracic… Read more »